Global Human Milk Oligosaccharides Market Set to Accelerate Growth to USD 850.5 Million by 2031, Backed by Expansion in Infant Formula and Functional Food Industries | DataM Intelligence

Leander, Texas - The Global Human Milk Oligosaccharides (HMO) Market was valued at USD 196.5 million in 2022 and is expected to reach USD 850.5 million by 2030, growing at an impressive CAGR of 20.1% during 2024-2031.

Market growth is fueled by rising demand for premium infant nutrition products, increasing awareness of the health benefits of HMOs, and advancements in biotechnology enabling large-scale, cost-effective production. Expanding applications in dietary supplements and functional foods are further accelerating market expansion.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/human-milk-oligosaccharides-market?ram

United States: Key Industry Developments

✅ July 2025: Companies like Abbott Nutrition and Nestlé Health Science continue to invest in expanding HMO-infused infant formula and adult nutrition products, particularly focusing on immune health and gut function benefits. Advances in fermentation technology enhance production capacity and cost efficiency for key HMOs such as 2'-FL and LNnT.

✅ June 2025: BENEO and WACKER announced a global strategic partnership to produce and launch 2'-Fucosyllactose (2'-FL) HMO, with WACKER managing precision fermentation in Europe and BENEO handling commercialization, aiming to secure supply for European infant formula manufacturers.

✅ March 2025: The market sees continued growth driven by increasing demand for HMO blends in infant formula to mimic breast milk benefits, alongside expansion into functional foods and dietary supplements focused on gut and immune health.

Asia Pacific / Japan: Key Industry Developments

✅ June 2025: The Asia-Pacific region experiences rapid premiumization in infant nutrition, with HMO-enriched formulas gaining popularity among working parents seeking advanced nutritional options for children.

✅ May 2025: BENEO and WACKER's launch of 2'-Fucosyllactose HMO benefits regional markets including Japan through increased availability of high-quality HMOs, supporting local manufacturers' supply chains and product innovation.

✅ Early 2025: Regulatory approvals and rising birth rates in Japan foster innovation in HMO-enriched infant nutrition products, with manufacturers focusing on clinical validation and tailored formulations to meet local consumer preferences and nutritional guidelines.

Key Mergers and Acquisitions (2025):

✅ DSM-Firmenich acquired Glycom in 2024, a key player in human milk oligosaccharides production, to enhance its biosynthesis capabilities and expand its portfolio of prebiotic ingredients. This acquisition strengthens DSM-Firmenich's leadership and capacity to meet rising demand for infant nutrition and gut health products.

✅ Nestlé Health Science has been developing multi-human milk oligosaccharide infant formulations, suggesting active product innovation and potential partnerships or acquisitions in this space to reinforce their market presence.

✅ BASF made strategic investments in precision fermentation technologies to improve the production of human milk oligosaccharides, which aligns with consolidation and innovation trends among major players.

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=human-milk-oligosaccharides-market?ram (Purchase 2 or more Reports and get 50% Discount)

Growth Drivers:

-Rising demand for infant nutrition products, especially those mimicking human breast milk.

-Increasing consumer awareness regarding the health benefits of HMOs, including gut health, immune support, and neurological development.

-Growing prevalence of infant formula products fortified with HMOs, driven by advances in biotechnology and personalized nutrition trends.

-Expanding applications of HMOs beyond infant nutrition into dietary supplements, functional foods, and cosmetics.

-Technological advancements enabling scalable production and regulatory approvals supporting broader market adoption.

-Regional growth momentum in Asia-Pacific due to rising infant population, higher healthcare spending, and increasing demand for high-nutrition foods.

Market Segmentation Analysis:

-By Product

Lacto-N-neotetraose (LNnT)

Lacto-N-tetraose (LNT)

2'-Fucosyllactose (2'FL): Expected to capture about 35% market share in 2025, driven by its role in enhancing immunity and gut health.

3'-Fucosyllactose (3'FL)

3'-Sialyllactose (3'SL)

6'-Sialyllactose (6'SL)

Others: Includes various trisaccharides and complex oligosaccharides with emerging health benefits.

-By Type

Neutral: Largest segment, widely used in infant formulas and dietary supplements.

Acidic: Includes sialylated HMOs important for brain development and immune function.

Others: Minor segment consisting of rare and specialized oligosaccharides.

-By Application

Infant Formula: Dominates the market with approximately 60% share as HMOs are increasingly added to mimic breast milk benefits.

Dietary Supplements: Growing segment focused on immune support and gut health in all age groups.

Functional Food and Beverages: Emerging applications in gut-health drinks, wellness shakes, and metabolic health products.

Others: Includes pharmaceuticals and clinical nutrition.

Regional Insights:

North America: North America holds a significant share of the global HMO market. It is the second-largest market with an estimated revenue of approximately USD 116.57 million in 2024 and expected to maintain a strong position in 2025. The region's dominance is driven by high consumer awareness, preventive healthcare trends, a strong network of supplement manufacturers, and pharmacies. The United States and Canada lead due to regulatory support, technological advances, and increasing demand for premium infant nutrition and personalized wellness products. The region benefits from a high disposable income and rising working mother population, driving demand for convenient, high-quality nutritional alternatives.​

Europe: Europe is the second-largest market after North America, with a projected market size of approximately USD 73.77 million in 2025. The leading countries are Germany, France, and the UK. The European market grows steadily, supported by consumer preference for natural, safe, and high-quality supplements, especially focusing on infant nutrition and chronic disease prevention. Regulatory frameworks classify HMO-based products as novel foods, ensuring safety and quality standards that build consumer trust. Health-conscious populations in this region maintain consistent demand for HMO-enriched formulas.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/human-milk-oligosaccharides-market?ram

Key Players:

Elicityl SA | Medolac Laboratories | Inbiose NV | Glycosyn | ZuChem | Jennewein Biotechnologie GmbH | Glycom A/S | Dextra Laboratories Limited | DuPont Nutrition & Health | Nestlé Health Science

Key Highlights (Top 5 Key Players) for Human Milk Oligosaccharides Market:

-Elicityl SA is a major player known for its technology and production of human milk oligosaccharides, contributing significantly to the market which is projected to reach USD 732.23 million by 2030 with a CAGR of 13.8%.​

-Nestlé Health Science (Nestlé S.A.) is identified as a forerunner in the market with strong innovations and partnerships, contributing to the overall market expected to hit around USD 1 billion by 2030.​

-DuPont Nutrition & Health reported solid market presence, with strategic collaborations such as the CARE4U 2'-FL development, positioning it among key innovators in the space.​

-Glycom A/S is listed among leading companies influencing the market trends with a strong focus on infant nutrition and HMO production.​

-Medolac Laboratories along with other specialized biotechnology firms such as Inbiose NV continue to build market share in the expanding infant nutrition and health supplement segments.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?ram

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.